- Automated Oxygen Control in Preterms on Non-invasive Ventilation — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07622563.
- What is being tested: Closed-loop automated oxygen control (CLAC) systems that automatically adjust oxygen delivery in preterm infants on non-invasive ventilation, compared to standard manual oxygen adjustment by clinical staff.
- Patient eligibility overview: Preterm infants receiving non-invasive respiratory support (such as CPAP or high-flow nasal cannula) who require supplementary oxygen therapy management.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
This randomised controlled trial aims to investigate the effectiveness of closed-loop automated oxygen control (CLAC) in preterm infants receiving non-invasive respiratory support and determine if it reduces the duration of supplementary oxygen treatment and improves achievement of oxygen saturation targets, reduces the incidences of hypoxia and hyperoxia, the number of manual adjustments to the inspired oxygen concentration (FiO2), and adverse outcomes including bronchopulmonary dysplasia (BPD). The study will take place at King's College Hospital neonatal intensive care unit (NICU). Parents of preterm infants born at less than 34 weeks of…
- : Preterm infants
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.